PsiOxus Therapeutics Ltd.
- Home
- Companies
- PsiOxus Therapeutics Ltd.
- Products
- PsiOxus - Model NG-XXX - Single or ...
PsiOxus - Model NG-XXX - Single or Multi-Protein Therapeutics Medicine
Novel transgene combinations. Our research team are developing a suite of viral vectors with new and innovative transgene inserts.
Most popular related searches
protein therapeutic
viral vector
intravenous injectable
immuno-oncology
therapeutic potential
intravenous injection
tumor microenvironment
T-cell
clinical trial
cancer treatment
Our approach to treating cancer involves selective delivery of single or multi-protein therapeutics to tumors via an intravenously injected viral vector. These therapeutics act locally to reprogram the tumor microenvironment, providing new treatment options for patients with cancer.
Our novel class of medicines expand the potential of immunotherapy to applications beyond T cell-rich ‘hot’ tumors, with therapeutic potential as both single agent and in combination with current immuno-oncology agents